4D Molecular Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
4D Molecular Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2019 to Q2 2024.
  • 4D Molecular Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 51.9M shares, a 23.6% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 51.9M +9.9M +23.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 51.2M +17.9M +53.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 43.1M +10.4M +32% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 42.8M +10.4M +32% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 42M +9.64M +29.8% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 33.2M +973K +3.02% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 32.6M +402K +1.25% Dec 31, 2022 10-K 2024-02-29
Q3 2022 32.4M +5.23M +19.2% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 32.4M +5.49M +20.4% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 32.3M +5.57M +20.9% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 32.2M +5.54M +20.8% Dec 31, 2021 10-K 2023-03-15
Q3 2021 27.2M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 26.9M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 26.7M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 26.7M +21.5M +415% Dec 31, 2020 10-K 2022-03-28
Q4 2019 5.18M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.